Clinical trials: Sepsis, completed
Sepsis Bacterial
A Case Report of a Patient With Intellectual Disability and Neurogenic Bladder Complicated With Sepsis
A case report of a patient with intellectual disability and neurogenic bladder complicated with sepsis
- Trial name
- NCT05727293
- Testing
- noting
- Where
- China
- Volunteers
- 1 people
- Sponsor
- Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Sepsis
Integration of NAVOY® Sepsis in an Electronic Health Record System
The study aims to evaluate the performance of NAVOY® Sepsis in predicting the sepsis risk in adult ICU patients. Data collection is performed via automatic retrieval from the electronic health record system to AlgoDx proprietary…
- Trial name
- GENIUS (NCT05095220)
- Where
- Sweden
- Volunteers
- 1,000 people
- Sponsor
- AlgoDx
Sepsis, Severe Sepsis
ED Tracking Sheet Implementation
The purpose of this study is to assess whether implementation of an ED Sepsis Tracking Sheet effects the percentage of goal-directed sepsis criteria met in a tertiary care academic Emergency Department.
- Conditions
- Sepsis, Severe Sepsis, Systemic Inflammatory Response Syndrome
- Trial name
- NCT05213923
- Testing
- ED Sepsis Tracking Sheet
- Where
- United States
- Volunteers
- 194 people
- Sponsor
- Dartmouth-Hitchcock Medical Center
E.Coli Infections, Bloodstream Infection
A Study Investigating the Safety, Recovery, and Pharmacodynamics of Multiple Oral Administrations of SNIPR001 in Healthy Subjects
This is a Phase 1, randomized, double-blind, placebo-controlled, multiple dose, dose escalation study in healthy participants, investigating the safety, tolerability, recovery, and PD of multiple oral administrations of SNIPR001.
- Trial name
- NCT05277350
- Testing
- SNIPR001
- Where
- United States
- Volunteers
- 36 people, healthy volunteers welcome
- Sponsor
- SNIPR Biome Aps.
Bloodstream Infection
Detection of Bloodstream Pathogens in Hematological Malignancies
To identify the common bacterial and fungal species causing fungemia and bacteremia in hematological malignancies. To identify sensitivity pattern for causative microbes.
- Trial name
- NCT03896880
- Testing
- blood culture, Anti fungal susceptibility testing or antibiotic susceptibility testing, phenotypic identification methods of the isolated organism by Vitek2 (BioMerieux,France)
- Where
- Egypt
- Volunteers
- 139 people
- Sponsor
- Assiut University
Sepsis, Septic Shock
Erythromycin in Septic Patients: Immunomodulatory Role and Clinical Impact
In sepsis and septic shock, the host response is characterized by a complex of immune-inflammatory reactions; triggered and activated by microbial components.
- Conditions
- Sepsis, Septic Shock, Immunoinflammatory Response
- Trial name
- NCT04665089
- Testing
- Erythromycin
- Where
- Tunisia
- Volunteers
- 110 people
- Sponsor
- Tunis University
Bloodstream Infections
Trial of Meropenem Versus Piperacillin-Tazobactam on Mortality and Clinial Response
Infections of the blood are extremely serious and require intravenous antibiotic treatment. When the infection results from antibiotic resistant bacteria, the choice of antibiotic is an extremely important decision.
- Trial name
- MERINO II (NCT02437045)
- Testing
- Meropenem, Piperacillin-tazobactam combination product
- Where
- 6 sites in Australia, Singapore
- Volunteers
- 100 people
- Sponsor
- The University of Queensland
Severe Sepsis
Lotta Alla Sepsi Ospedaliera - Fighting Hospital Sepsis
Sepsis is widespread (1.8 million cases annually worldwide) and accounts for a very high mortality: 20-25% of all severe sepsis, 40-70% of all septic shock.
- Trial name
- NCT01804764
- Where
- Italy
- Volunteers
- 1,123 people
- Sponsor
- University of Milano Bicocca
Septic Shock, Sepsis
Decatecholaminisation of Septic Shock With Dexmedetomidine and In-hospital Mortality
The study aims to determine whether the infusion of DEX in septic shock can reduce in-hospital mortality, norepinephrine infusion, need and duration for mechanical ventilation, and acute kidney injury without significant adverse…
- Trial name
- DECATSepsis (NCT05283083)
- Testing
- Dexmedetomidine
- Where
- Egypt
- Volunteers
- 90 people
- Sponsor
- Mansoura University
Sepsis at Intensive Care Unit
Validation of a Urinary Biomarker as Diagnostic Tool for AKI in Sepsis
BACKGROUND: Early diagnosis and prognostication of acute kidney injury in patients with sepsis is key to further our understanding this disease and in the evaluation of new interventions for this condition.
- Trial name
- NCT01981993
- Testing
- Urinary proteomic analysis
- Where
- Belgium
- Volunteers
- 150 people
- Sponsor
- University Hospital, Ghent
Sepsis
Prediction of Disease Severity in Young Children Presenting With Acute Febrile Illness in Resource-limited Settings
Note that this is a study that is co-sponsored by Medecins Sans Frontieres, Spain, and the University of Oxford. The primary objective is to develop a risk prediction algorithm, combining measurements of host biomarkers and…
- Trial name
- SPOT-SEPSIS (NCT04285021)
- Where
- 6 sites in Bangladesh, Cambodia and 3 more
- Volunteers
- 3,433 people
- Sponsor
- Medecins Sans Frontieres, Spain
Sepsis, Septic Shock
Implementation Trial of Predictive Modeling to Enhance Diagnosis and Improve Treatment in Pediatric Septic Shock
This study is a prospective, stepped-wedge implementation trial to test the effects of implementing a Clinical Decision Support (CDS) tool for prediction of septic shock in four Emergency Departments within a pediatric healthcare…
- Conditions
- Sepsis, Septic Shock, Emergencies
- Trial name
- NCT05065333
- Testing
- Septic Shock Clinical Decision Support, Clinical Diagnosis Only
- Where
- United States
- Volunteers
- 1,345 people
- Sponsor
- University of Colorado, Denver
Sepsis
The Efficacy and Safety of Ta1 for Sepsis
The purpose of this study is to determine whether thymalfasin is safe and effective in patients who have sepsis
- Trial name
- TESTS (NCT02867267)
- Testing
- Thymosin alpha 1
- Where
- 22 sites in China
- Volunteers
- 1,106 people
- Sponsor
- Sun Yat-sen University
Norepinephrine, Sepsis
The Impact of Early Norepinephrine Administration on Outcomes of Patients With Sepsis-induced Hypotension
Septic shock is defined as sepsis with persistent hypotension requiring vasopressors to maintain mean arterial pressure (MAP)≥ 65 mmHg and a serum lactate level of > 2 mmol/L (18 mg/dL) despite sufficient volume resuscitation .
- Conditions
- Norepinephrine, Sepsis, Hypotension
- Trial name
- NCT05774054
- Testing
- Crystalloid, noradrenaline
- Where
- Egypt
- Volunteers
- 64 people
- Sponsor
- Tanta University
Sepsis
Electronic Early Notification of Sepsis in Hospitalized Ward Patients
Screening for sepsis has been recommended by the Surviving Sepsis Campaign Clinical Practice Guidelines to facilitate early identification and early management of sepsis.
- Trial name
- SCREEN (NCT04078594)
- Testing
- sepsis e-alert
- Where
- Saudi Arabia
- Volunteers
- 65,250 people
- Sponsor
- King Abdullah International Medical Research Center
Sepsis, Septic Cardiomyopathy
Identification of Cardiovascular and Molecular Prognostic Factors for the Mid- and Long-term Outcome of Sepsis
Sepsis is a life-threatening condition which can affect people of any age. An infection triggers a host response resulting in organ failure.
- Conditions
- Sepsis, Septic Cardiomyopathy, Cardiomyopathies
- Trial name
- ICROS (NCT03620409)
- Where
- Germany
- Volunteers
- 308 people, healthy volunteers welcome
- Sponsor
- Jena University Hospital
Meningococcal Infections, Neisseria Meningitis Sepsis
The Long-term Impact of Invasive Meningococcal Disease in Australian Adolescents and Young Adults
Survivors of invasive meningococcal disease (IMD) experience a range of mild to severe sequelae that impact upon their quality of life.
- Conditions
- Meningococcal Infections, Neisseria Meningitis Sepsis, Neisseria Infection
- Trial name
- AMEND (NCT03798574)
- Where
- 4 sites in Australia
- Volunteers
- 98 people, healthy volunteers welcome
- Sponsor
- University of Adelaide
Coronavirus Infection, Sepsis
Annexin A5 in Patients With Severe COVID-19 Disease
Randomized, double-blind, placebo-controlled trial comparing 2 doses of SY-005 (recombinant human Annexin A5) to placebo in patients with severe coronavirus 2019 disease in a single hospital centre with 2 intensive care units
- Trial name
- AX-COVID (NCT04748757)
- Testing
- recombinant human annexin A5
- Where
- Canada
- Volunteers
- 18 people
- Sponsor
- London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Infections Resistant to Multiple Drugs, Bacterial Infections
Multi-Drug Resistant Organism Network
This study is specifically designed to provide observational data which can be used to help in the design of future randomized clinical trials on both therapeutics and diagnostics for MDRO infections.
- Trial name
- MDRO Network (NCT03646227)
- Testing
- Standard of Care
- Where
- 4 sites in United States, Australia and 2 more
- Volunteers
- 6,496 people
- Sponsor
- Duke University
Zinc in Pediatric Sepsis
Zinc Supplementation in Pediatric Sepsis
a single blinded randomized controlled clinical trial that was conducted to evaluate the role of zinc supplementation in improving the outcome of infants and children with sepsis in pediatric intensive care unit.
- Trial name
- NCT05366595
- Testing
- oral zinc sulfate
- Where
- Egypt
- Volunteers
- 72 people
- Sponsor
- Mansoura University